Michael Nissen

Criticizing the Trial to Asess Chelation Therapy (TACT) is defending science-based medicine

oracknows | March 27, 2013

When I wrote about the Trial to Assess Chelation Therapy (TACT) trial last week, little did I suspect that I would be revisiting the topic again so soon. For those of you not familiar with TACT, it was a trial designed to test a favorite quack treatment for cardiovascular disease, chelation therapy. It is, as I have described many times in the past, an incredibly implausible therapy based on a hugely simplistic concept that because calcium accumulates in atherosclerotic lesions, then using chelation therapy could remove the calcium and reduce the lesions. Chelation therapy is a favorite…

Advertisment

Donate

ScienceBlogs is where scientists communicate directly with the public. We are part of Science 2.0, a science education nonprofit operating under Section 501(c)(3) of the Internal Revenue Code. Please make a tax-deductible donation if you value independent science communication, collaboration, participation, and open access.

You can also shop using Amazon Smile and though you pay nothing more we get a tiny something.

Science 2.0

Science Codex

Criticizing the Trial to Asess Chelation Therapy (TACT) is defending science-based medicine

"Stiff Nights" Falls on Hard Times

Sea Level Rise & Greenland Ice Melt: Ruh Roh.

Mystery Volcano Photo #7